Difference between revisions of "Team:Amoy/Notebook"

Line 242: Line 242:
 
</g>
 
</g>
 
<g class="node" transform="translate(200,350)">
 
<g class="node" transform="translate(200,350)">
<circle r="10" style="fill: pruple;"></circle>
+
<circle r="10" style="fill: DarkBlue;"></circle>
 
<text dx="-8" dy="3" style="text-anchor: start;">3.2</text>
 
<text dx="-8" dy="3" style="text-anchor: start;">3.2</text>
 
</g>
 
</g>
 
<g class="node" transform="translate(250,350)">
 
<g class="node" transform="translate(250,350)">
<circle r="10" style="fill: pruple;"></circle>
+
<circle r="10" style="fill: DarkBlue;"></circle>
 
<text dx="-8" dy="3" style="text-anchor: start;">3.3</text>
 
<text dx="-8" dy="3" style="text-anchor: start;">3.3</text>
 
</g>
 
</g>
 
<g class="node" transform="translate(300,350)">
 
<g class="node" transform="translate(300,350)">
<circle r="10" style="fill: pruple;"></circle>
+
<circle r="10" style="fill: DarkBlue;"></circle>
 
<text dx="-8" dy="3" style="text-anchor: start;">3.4</text>
 
<text dx="-8" dy="3" style="text-anchor: start;">3.4</text>
 
</g>
 
</g>

Revision as of 16:30, 9 September 2015

Aomy/Project

NOTEBOOK

Document the dates you worked on your project.

Initially, they used isolated enzymes, which can be disadvantageous for the reason that enzymes are always destabilized in the isolation and purification process. What's more, the cofactor-NADH is rather an expensive raw material, which will enhance the cost of L-tert-leucine production. So scientists introduced whole-cell biocatalysts to L-tert-leucine production. Whole-cell biocatalysts could stabilize enzymes and reduce the addition level of cofactor NADH.

China 1 1.1 1.2 1.3 1.4 2 2.1 2.1.1 2.1.2 2.1.3 2.1.4 2.2 2.3 2.4 3 3.1 3.2 3.3 3.4 4 4.1 4.2 4.3 4.4 4.4

CONTACT US

Email: igemxmu@gmail.com

Website: 2015.igem.org/Team:Amoy

Address: Xiamen University, No. 422, Siming South Road, Xiamen, Fujian, P.R.China 361005